The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells.

Eierhoff T, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C. · 2010

Read The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. by Eierhoff T, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2936548.txt.

Introduction

Eierhoff and colleagues showed in 2010 that a cell surface receptor best known for growth signals helps influenza A viruses enter host cells. Flu viruses attach to sugars on the cell surface and slip inside, a step needing signals from the cell itself.

Raising or blocking the activity of the epidermal growth factor receptor, and of a related receptor called c-Met, changed how much virus got in. Virus binding gathered fatty raft patches in the membrane, switching the receptor on. The finding names a host doorway that antiviral drugs might one day block to slow infection.

Catalog record

CREATOREierhoff T, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2936548

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The Epidermal Growth Factor Receptor (EGFR) Promotes Uptake of Influenza A Viruses (IAV) into Host Cells By Thorsten Eierhoff, Eike R Hrincius, Ursula Rescher, Stephan Ludwig, Christina Ehrhardt, Ron A M Fouchier Published in: PLoS Pathogens DOI: 10.1371/journal.ppat.1001099 ABSTRACT Abstract Influenza A viruses (IAV) bind to sialic-acids at cellular surfaces and enter cells by using endocytotic routes. There is evidence that this process does not occur constitutively but requires induction of specific cellular signals, including activation of PI3K that promotes virus internalization. This implies engagement of cellular signaling receptors during viral entry. Here, we present first indications for an interplay of IAV with receptor tyrosine kinases (RTKs). As representative RTK family-members the epidermal growth factor receptor (EGFR) and the c-Met receptor were studied. Modulation of expression or activity of both RTKs resulted in altered uptake of IAV, showing that these receptors transmit entry relevant signals upon virus binding. More detailed studies on EGFR function revealed that virus binding lead to clustering of lipid-rafts, suggesting that multivalent binding of IAV to cells induces a signaling platform leading to activation of EGFR and other RTKs that in turn facilitates IAV uptake. INTRODUCTION Influenza A viruses are enveloped viruses that possess a single strand RNA genome with negative orientation. As cell obligate parasites IAV have to enter host cells to ensure efficient replication and propagation by abusing the cellular machinery. Like other enveloped viruses IAV enter the cell by endocytotic routes [1]. The particles are internalized via clathrin-mediated or clathrin and calveolin-independent endocytosis [2]. IAV binds to sialic acid residues at the host cell surface via the viral glycoprotein hemagglutinin (HA). However, these structures possess no signaling capacity and are, thus, not sufficient to induce host cell signaling, which is required to sort the virus particles into specific endocytotic routes. Therefore, it was hypothesized quite early on that engagement of specific signaling-receptors may be required for efficient viral entry [3]. However, the identity of such receptors remained enigmatic. Among the signaling components, which are induced upon IAV binding are the protein kinase C (PKC) [4], the extracellular signal-regulated kinase ERK [5] and the phosphatidylinositol-3 kinase (PI3K) [6]. PKC has been implicated to be involved in entry processes of various viral pathogens such as rhabdoviruses, alphaviruses, poxviruses, herpesviruses, and IAV [7], [8]. Upon IAV infection, PKC is activated upon attachment of the viral HA to the cell-surface [4]. Activation of the isoform PKCβII results in sorting of the virus particles into the late endosomes [8]. In addition, activation of PI3K and ERK1/2 has been described during entry of human cytomegalovirus [9], [10]. PI3K activation was not only shown to be crucial for IAV entry [6] but also has been demonstrated to regulate vesicular uptake, and trafficking of Ebola viruses [11]. However, it is still elusive, how signaling events are initiated upon early IAV binding and how these signals are transmitted to mediate PKC, ERK and PI3K activation. A major mechanism that transforms extracellular signals to intracellular PI3K and ERK1/2 activation is the engagement of receptor tyrosine kinases (RTKs). Among the family of RTKs the group of epidermal growth factor receptors, consisting of four members (EGF-, ErbB2-, ErbB3 and ErbB4-receptors) are well studied (reviewed in [12]). Parallels between sorting pathways for the epidermal growth factor receptor (EGFR) and IAV have been identified. Both use endocytotic mechanisms during internalization and require protein ubiquitinylation to be sorted into the vacuolar protein synthesis machinery [13]. Since it was shown that IAV and EGFR were sorted into the same population of late endosomes [2], we hypothesized that RTKs, such as the EGFR may be involved to induce IAV uptake. In this study we investigated the role of EGFR and c-Met, the receptor of hepatocyte growth factor, as candidate RTKs, in IAV entry processes. Broad inhibition of tyrosine kinases by small molecule inhibitors as well as specific EGFR or c-Met inhibition via siRNA mediated knock-down resulted in reduced virus uptake and subsequently to reduced progeny virus titers. Attachment of IAV resulted in clustering of plasma membrane lipids, comparable to EGF stimulation. Our data suggest that IAV is a multivalent agent that, upon binding to sialic acids, is able to cluster and activate EGFR and other RTKs to form a lipid raft-based signaling platform. This leads to receptor-mediated signaling events, such as PI3K/Akt activation, which enhances IAV uptake. RESULTS Inhibition of tyrosine kinase activity leads to impaired IAV uptake into cells To examine the role of RTKs in IAV entry processes, we treated human A549 lung epithelial cells with the broad-range tyrosine kinase inhibitor genistein prior to infection. To detect incoming virus particles cells were infected with a high multiplicity of infection (MOI) and the viral HA was visualized by immunofluorescence (IF) (Figure 1A) as previously described [8]. While in solvent treated cells virus particles were internalized into endosomes 30 min post infection (p.i.) (Figure 1A, upper left panel and z-axis view), in genistein treated cells a completely different staining pattern was observed. A major portion of virus particles appeared to remain stuck to the cell surface (Figure 1A, upper right panels, white arrow heads and z-axis view). To demonstrate the specific inhibitory effect of genistein on the endocytosis of RTKs, we compared the internalization of the EGFR and transferrin (supplementary Figure S1). The EGFR is a representative and ubiquitously expressed family member of RTKs, while transferrin is a glycoprotein, which is internalized independently from RTKs [14]. While transferrin uptake was not affected by genistein treatment, as evidenced by colocalization of transferrin and the early endosomal antigen 1 (EEA1), EGF-induced EGFR internalization was decreased, resulting in a reduced colocalization of EGFR and EEA1 (Figure S1, upper panel). To independently confirm the IF data (Figure 1A), IAV internalization was visualized by detection of virion-associated matrix protein (M1) in Western-blot analysis (Figure 1B) as described by Eierhoff and colleagues [15]. Selective detection of M1 of internalized IAV particles was achieved by applying an acidic washing step before cell lysis to remove attached but not yet internalized virions [15]. [Figure: Tyrosine kinase activity is required for efficient uptake of IAV.(A, B, C) A549 cells were treated with genistein (50 µM, [+]) or (D, E) a mixture of several RTK inhibitors (each 10 µM, [+] see experimental procedures) or the solvent control (DMSO,[−]) respectively for 60 min at 37°C or over night prior to infection. (A) Upon genistein treatment, cells were either mock infected or infected with influenza virus A/FPV/Bratislava/79 (H7N7) (FPV; MOI = 100) for further 30 min. Virus particles were visualized in immunofluorescence (IF) microscopy, via a hemagglutinin (HA)-specific rabbit antiserum and an Alexa 594-conjugated chicken anti-rabbit IgG. The nuclei were stained with DAPI. The white arrowheads point to virus particles lining at the cell border. (B, D) After infection with influenza virus A/Puerto-Rico/8/34 (H1N1) PR8 (MOI = 8) for further 30 min, an acidic wash (PBS, pH 1.3, 4°C) was performed before cell-lysis. Internalized virus particles were visualized with a M1 monoclonal antibody in Western-blot (WB) analysis. Equal protein load was verified by ERK2 detection. The relative amount of M1 was quantified (B and D lower panels). Relative M1 densities are expressed as mean ±SD of three independent experiments. (C, E) Cells were infected with FPV or PR8 (MOI = 4) for

Read the complete text